Bedel Financial Consulting’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-1,200
Closed -$55K – 282
2022
Q1
$55K Hold
1,200
– – 0.02% 373
2021
Q4
$58K Buy
+1,200
New +$56.8K 0.02% 371

Other funds holding BME

Bedel Financial Consulting's BME Position: Q2 2022 in Review

Bedel Financial Consulting sold out of BlackRock Health Sciences Trust (BME) in Q2 2022, closing a stake of 1,200 shares — an estimated $55K sold.

Bedel Financial Consulting first reported a position in BME in Q4 2021 and held it in 2 quarters. The position peaked at $58K in Q4 2021. 62 funds tracked by Wall St. Rank hold BME as of Q2 2022.

  • Bedel Financial Consulting reported no remaining BlackRock Health Sciences Trust position as of Q2 2022 after selling out during the quarter.
  • Bedel Financial Consulting sold 1,200 BlackRock Health Sciences Trust shares in Q2 2022, an estimated $55K.
  • Bedel Financial Consulting first reported a position in BlackRock Health Sciences Trust in Q4 2021 and held it in 2 quarters.
  • Bedel Financial Consulting's BlackRock Health Sciences Trust position peaked at $58K in Q4 2021.
  • 62 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2022.

Based on Bedel Financial Consulting's 13F filing for Q2 2022, filed 4 Aug 2022.